Ratite extracts as therapeutic agents

Details Ratite extracts as therapeutic agents Ratite extracts as therapeutic agents

1997-08-08

1999-11-23

Witz, Jean C.

Drug, bio-affecting and body treating compositions

Extract, body fluid, or cellular material of undetermined...

Derived from musculoskeletal system, other than cardiac muscle

A61K 3534

Patent

active

059895942

ABSTRACT:
Adenosine triphosphate (ATP) deficiency is the cause of many autoimmune, muscle and bone wasting disorders in humans and animals. Ratite muscle and bone extracts provide a rich source of ATP and regulatory proteins which can be used in treating conditions associated with ATP deficiency.

REFERENCES:
patent: 5202144 (1993-04-01), Yaiko
patent: 5431924 (1995-07-01), Ghosh et al.
patent: 5472713 (1995-12-01), Fein et al.
Offerman et al., Journal of Nutrition in Recipe and Menu Development 2(2): 41-48 (1995). Abstract, 1995.
Noble, R.C. et al.: Yolk Lipids and Their Fatty Acids in the Wild and Captive Ostrich (Struthio camelus). Comp. Biochem. Physiol., 1996, vol. 113B, No. 4, pp. 753-756.
Dearing, J.D.: Rubber Rheas Revisited. Ratite Marketplace, Feb. 24, 1994: 29-30.
Speer, B.L.: Fading Chick Syndrome. American Ostrich, Aug. 1994: 30-31, 82, 85-86.
Smith, C.A.: Ostrich chick survival presents challenge. JAVMA, vol. 203, No. 5: Sep. 1, 1993: 637-643.

Affiliated with

Also associated with

Rating

Ratite extracts as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ratite extracts as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ratite extracts as therapeutic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1218526